publicaciones seleccionadas artículo académico Bromhexine inhibits SARS-CoV-2 Omicron and variant pseudovirus infection via ACE2-targeted mechanisms. FRONTIERS IN PHARMACOLOGY. 16. 2026 Identification of Potential Multitarget Directed Ligands for Alzheimer's Disease by Coupling Virtual Screening and Experimental Validation. JOURNAL OF CHEMICAL INFORMATION AND MODELING. 66(5):2900-2917. 2026 Molecular Mechanism of Beta-Amyloid Aggregation Inhibition by KLVFF. JOURNAL OF CHEMICAL INFORMATION AND MODELING. 66(1):684-700. 2026 Differential Effects of Marimastat and Prinomastat on the Metalloprotease Activity of Various Snake Venoms. TOXINS. 17(12). 2025 Discovery of a brain penetrant SGK1 inhibitor using a ligand- and structure-based virtual screening methodology. JOURNAL OF ENZYME INHIBITION AND MEDICINAL CHEMISTRY. 40(1). 2025 Identification of druggable binding sites and small molecules as modulators of TMC1. COMMUNICATIONS BIOLOGY. 8(1). 2025 MicroRNA signature of lymphoblasts from amyotrophic lateral sclerosis patients as potential clinical biomarkers. NEUROBIOLOGY OF DISEASE. 208. 2025 Novel neuroglobin boosters as a therapeutic strategy for traumatic brain injury. INTERNATIONAL IMMUNOPHARMACOLOGY. 159. 2025 The ROCK Inhibitor Fasudil and Sertraline Share Morphological and Molecular Effects in the Hippocampus of Chronically Stressed Rats: Exploring Common Antidepressant Pathways by Network Pharmacology. ACS PHARMACOLOGY & TRANSLATIONAL SCIENCE. 8(5):1292-1312. 2025 AlzyFinder: A Machine-Learning-Driven Platform for Ligand-Based Virtual Screening and Network Pharmacology. JOURNAL OF CHEMICAL INFORMATION AND MODELING. 64(24):9040-9047. 2024 Antibacterial and Antiviral Properties of Chenopodin-Derived Synthetic Peptides. ANTIBIOTICS-BASEL. 13(1). 2024 Constitutive sodium permeability in a C. elegans two-pore domain potassium channel. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA. 121(43). 2024 Druggable cavities and allosteric modulators of the cell division cycle 7 (CDC7) kinase. JOURNAL OF ENZYME INHIBITION AND MEDICINAL CHEMISTRY. 39(1). 2024 Enzymatic Metabolic Switches of Astrocyte Response to Lipotoxicity as Potential Therapeutic Targets for Nervous System Diseases. PHARMACEUTICALS. 17(5). 2024 Identification of Antioxidant Methyl Derivatives of Ortho-Carbonyl Hydroquinones That Reduce Caco-2 Cell Energetic Metabolism and Alpha-Glucosidase Activity. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES. 25(15). 2024 Impedimetric Sensor for SARS-CoV-2 Spike Protein Detection: Performance Assessment with an ACE2 Peptide-Mimic/Graphite Interface. BIOSENSORS. 14(12). 2024 Intragastric administration of short chain fatty acids greatly reduces voluntary ethanol intake in rats. SCIENTIFIC REPORTS. 14(1). 2024 Phase IIa randomized placebocontrolled clinical trial to evaluate the efficacy of bromhexine in combination with standard therapy in the early treatment of COVID-19 in primary care patients. REVISTA MEDICA DE CHILE. 152(12):1198-1208. 2024 Repurposing the Open Global Health Library for the discovery of novel Mpro destabilizers with scope as broad-spectrum antivirals. FRONTIERS IN PHARMACOLOGY. 15. 2024 Anti-Inflammatory Effect of Izalpinin Derived from Chromolaena leivensis: ¿-Carrageenan-Induced Paw Edema and In Silico Model. MOLECULES. 28(9). 2023 Design of ß-Keto Esters with Antibacterial Activity: Synthesis, In Vitro Evaluation, and Theoretical Assessment of Their Reactivity and Quorum-Sensing Inhibition Capacity. PHARMACEUTICALS. 16(10). 2023 Iridoid esters from Valeriana pavonii Poepp. & Endl. as GABAA modulators: Structural insights in their binding mode and structure-activity relationship. JOURNAL OF PHARMACY & PHARMACOGNOSY RESEARCH. 11(3):367-380. 2023 Network pharmacology and topological analysis on tibolone metabolites and their molecular mechanisms in traumatic brain injury. BIOMEDICINE & PHARMACOTHERAPY. 165. 2023 Trends and challenges in chemoinformatics research in Latin America. ARTIFICIAL INTELLIGENCE IN THE LIFE SCIENCES. 3. 2023 Common Structural Pattern for Flecainide Binding in Atrial-Selective Kv1.5 and Nav1.5 Channels: A Computational Approach. PHARMACEUTICS. 14(7). 2022 Crystal structure, Hirshfeld surface analysis, and molecular dynamics simulations of two isostructural N-propargyl-4-(2-oxopyrrolidin-1-yl)-1,2,3,4-tetrahydroquinolines. JOURNAL OF MOLECULAR STRUCTURE. 1254. 2022 Identification of HMGCR, PPGARG and prohibitin as potential druggable targets of dihydrotestosterone for treatment against traumatic brain injury using system pharmacology. INTERNATIONAL IMMUNOPHARMACOLOGY. 108. 2022 Network pharmacology reveals multitarget mechanism of action of drugs to be repurposed for COVID-19. FRONTIERS IN PHARMACOLOGY. 13. 2022 Selective TASK-1 Inhibitor with a Defined Structure-Activity Relationship Reduces Cancer Cell Proliferation and Viability. JOURNAL OF MEDICINAL CHEMISTRY. 65(22):15014-15027. 2022 Structural Insights into the Substrate Transport Mechanisms in GTR Transporters through Ensemble Docking. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES. 23(3). 2022 TDP-43 Modulation by Tau-Tubulin Kinase 1 Inhibitors: A New Avenue for Future Amyotrophic Lateral Sclerosis Therapy. JOURNAL OF MEDICINAL CHEMISTRY. 65(2):1585-1607. 2022 Tibolone Pre-Treatment Ameliorates the Dysregulation of Protein Translation and Transport Generated by Palmitic Acid-Induced Lipotoxicity in Human Astrocytes: A Label-Free MS-Based Proteomics and Network Analysis. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES. 23(12). 2022 5-(Indol-2-yl)pyrazolo[3,4-b]pyridines as a New Family of TASK-3 Channel Blockers: A Pharmacophore-Based Regioselective Synthesis. MOLECULES. 26(13). 2021 Antimicrobial properties of novel ionic liquids derived from imidazolium cation with phenolic functional groups. BIOORGANIC CHEMISTRY. 115. 2021 Application of ensemble pharmacophore-based virtual screening to the discovery of novel antimitotic tubulin inhibitors. COMPUTATIONAL AND STRUCTURAL BIOTECHNOLOGY JOURNAL. 19:4360-4372. 2021 From Kinase Inhibitors to Multitarget Ligands as Powerful Drug Leads for Alzheimer's Disease using Protein-Templated Synthesis. ANGEWANDTE CHEMIE-INTERNATIONAL EDITION. 60(35):19344-19354. 2021 Host-Directed FDA-Approved Drugs with Antiviral Activity against SARS-CoV-2 Identified by Hierarchical In Silico/In Vitro Screening Methods. PHARMACEUTICALS. 14(4). 2021 Identification of a critical binding site for local anaesthetics in the side pockets of K(v)1 channels. BRITISH JOURNAL OF PHARMACOLOGY. 178(15):3034-3048. 2021 PSC-db: A Structured and Searchable 3D-Database for Plant Secondary Compounds. MOLECULES. 26(4). 2021 Screening for Interacting Proteins with Peptide Biomarker of Blood-Brain Barrier Alteration under Inflammatory Conditions. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES. 22(9). 2021 Targeting nuclear protein TDP-43 by cell division cycle kinase 7 inhibitors: A new therapeutic approach for amyotrophic lateral. EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY. 210. 2021 Analysis of theZonula occludensToxin Found in the Genome of the Chilean Non-toxigenicVibrio parahaemolyticusStrain PMC53.7. FRONTIERS IN CELLULAR AND INFECTION MICROBIOLOGY. 10. 2020 COVID-19: Drug Targets and Potential Treatments. JOURNAL OF MEDICINAL CHEMISTRY. 63(21):12359-12386. 2020 Elucidating the Structural Basis of the Intracellular pH Sensing Mechanism of TASK-2 K2P Channels. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES. 21(2). 2020 Identification of Mycobacterium tuberculosis CtpF as a target for designing new antituberculous compounds. BIOORGANIC & MEDICINAL CHEMISTRY. 28(3). 2020 Structural and functional computational analysis of nicotine analogs as potential neuroprotective compounds in Parkinson disease. COMPUTATIONAL BIOLOGY AND CHEMISTRY. 86. 2020 Discovery of Novel TASK-3 Channel Blockers Using a Pharmacophore-Based Virtual Screening. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES. 20(16). 2019 Structure/Activity Analysis of TASK-3 Channel Antagonists Based on a 5,6,7,8 tetrahydropyrido[4,3-d]pyrimidine. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES. 20(9). 2019 TASK Channels Pharmacology: New Challenges in Drug Design. JOURNAL OF MEDICINAL CHEMISTRY. 62(22):10044-10058. 2019 The interplay of the metallosensor CueR with two distinct CopZ chaperones defines copper homeostasis in Pseudomonas aeruginosa. JOURNAL OF BIOLOGICAL CHEMISTRY. 294(13):4934-4945. 2019 The molecular basis for an allosteric inhibition of K+-flux gating in K-2P channels. ELIFE. 8. 2019 An important role for periplasmic storage in Pseudomonas aeruginosa copper homeostasis revealed by a combined experimental and computational modeling study. MOLECULAR MICROBIOLOGY. 110(3):357-369. 2018 Is It Reliable to Take the Molecular Docking Top Scoring Position as the Best Solution without Considering Available Structural Data?. MOLECULES. 23(5). 2018 Novel Alkylimidazolium Ionic Liquids as an Antibacterial Alternative to Pathogens of the Skin and Soft Tissue Infections. MOLECULES. 23(9). 2018 Exploring and understanding the functional role, and biochemical and structural characteristics of an acidic phospholipase A(2), ApITx-I, purified from Agkistrodon piscivorus leucostoma snake venom. TOXICON. 127:22-36. 2017 Origin and evolution of transporter substrate specificity within the NPF family. ELIFE. 6. 2017 Side Fenestrations Provide an "Anchor" for a Stable Binding of A1899 to the Pore of TASK-1 Potassium Channels. MOLECULAR PHARMACEUTICS. 14(7):2197-2208. 2017 CoaTx-II, a new dimeric Lys49 phospholipase A(2) from Crotalus oreganus abyssus snake venom with bactericidal potential: Insights into its structure and biological roles. TOXICON. 120:147-158. 2016 Computational methods applied to rational drug design. OPEN MEDICINAL CHEMISTRY JOURNAL. 10:7-20. 2016 Functional mutagenesis screens reveal the 'cap structure' formation in disulfide-bridge free TASK channels. SCIENTIFIC REPORTS. 6. 2016 Is It Reliable to Use Common Molecular Docking Methods for Comparing the Binding Affinities of Enantiomer Pairs for Their Protein Target?. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES. 17(4). 2016 Novel N-allyl/propargyl tetrahydroquinolines: Synthesis via Three-component Cationic Imino Diels-Alder Reaction, Binding Prediction, and Evaluation as Cholinesterase Inhibitors. CHEMICAL BIOLOGY & DRUG DESIGN. 88(4):498-510. 2016 Kv1.5 blockers preferentially inhibit TASK-1 channels: TASK-1 as a target against atrial fibrillation and obstructive sleep apnea?. PFLUGERS ARCHIV-EUROPEAN JOURNAL OF PHYSIOLOGY. 467(5):1081-1090. 2015 Computational insights of the interaction among sea anemones neurotoxins and Kv1.3 channel. BIOINFORMATICS AND BIOLOGY INSIGHTS. 8:73-81. 2014 Theoretical and Experimental Exploration of Organic Synthesis Routes to Obtain Natural Rubber Analogues. JOURNAL OF MATERIALS SCIENCE AND ENGINEERING A. 4(9):290-296. 2014 libro Pharmacoinformatics: New developments and challenges in drug design 2024